Cytosorbents Corp
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Princeton, NJ
CTSO chart
What traders are saying about $CTSO
Latest postsCytosorbents Corp news
- CytoSorbents execs to meet investors at Jefferies Global Healthcare Conference in London Nov 16-18
Pluang ·
- CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London
Yahoo Finance ·
- CTSO: 73% Q2 gross margin and ~$200K operating cash burn; breakeven targeted in 2H 2026
TradingView ·
- CTSO Q3'26 Earnings: revenue estimate is 9.90M USD
TradingView ·
- CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance ·
- CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care
Yahoo Finance ·
- CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance ·
- CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Yahoo Finance ·
- CytoSorbents Announces Reverse Stock Split
Yahoo Finance ·
- CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
Yahoo Finance ·
- CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
Yahoo Finance ·
Cytosorbents Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.2M | -$20.7M | -$29.2M | -$32.8M |
| Diluted EPS | $-0.13 | $-0.38 | $-0.65 | $-0.75 |
| Total assets (year end) | $44.2M | $47.4M | $53.0M | $63.2M |
| Cash and equivalents (year end) | $6.2M | $3.3M | $14.1M | $22.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cytosorbents Corp
- Ticker
- CTSO (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1175151
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
Frequently asked questions
What exchange is Cytosorbents Corp listed on?
Cytosorbents Corp trades on the Nasdaq under the ticker symbol CTSO.
What industry is Cytosorbents Corp in?
Cytosorbents Corp is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Cytosorbents Corp headquartered?
Cytosorbents Corp's business address on file with the SEC is in Princeton, NJ.
When does Cytosorbents Corp's fiscal year end?
Cytosorbents Corp's fiscal year ends on December 31.
How much revenue did Cytosorbents Corp report?
Cytosorbents Corp reported $22.5M in revenue for calendar year 2018, according to its SEC filings.